Squamous Cell Lung Cancer
Squamous Cell Lung Cancer is a pulmonary neoplasm that is not benign. There is always additional clinical emphasis given whenever a patient is affected with this type of pulmonary neoplasm. Squamous cell lung cancer is epithelial in origin. This type of neoplasm has no boundaries in its growth or spread within the different lobes of lungs.
This cancer in lungs is due to the smoking of cigarettes or cigars either by the smoker or by the nonsmoker who is routinely in the same room during smoking. The signs and symptoms of squamous cell lung cancer are similar to any type of a severe pulmonary neoplasm such as coughing up bloody material, difficulty breathing (dyspnea), and weight loss.
Squamous cell lung cancer is considered a destructive neoplasm in the lungs. Therefore, additional attention is given incorporating support in anti-cancerous therapy involving multi-drug combinations. Supportive therapy may include usage of suitable corticosteroid drugs like prednisolone in a routine form, and in some patients a repository form of this corticosteroid may also be used to fulfill the need of constant delivery. Surgery is also being considered as therapy, but if the spread of the cancer is over a wide area, it becomes impossible.
In many patients, this tends to spread to other tissues including kidney or bone. Assuming it spreads to bones, most of the times, the mandible or skull may get affected. In such cases increased density with occurrence of periosteal new bones may be noticed.
Squamous cell lung cancer may need additional confirmation from more pathologists who are specialized in such diagnosis. Clinical effects seen in one patient affected by this type of cancer may not reflect the same affects in other patients. Factors like target organ of cancer cells, compromise of the immune status of the patient, effects of medications including alternate drug therapy which may even include restrictions in multiple diets in order to avoid constant exposure to the carcinogens that have some association with food components, etc. All of these indicate multiple factors that are associated with the production of squamous cell lung cancer.
It is advantageous to stay abreast of updated technical information on various pathogenesis and factors associated with signs and symptoms of this cancer in lungs involving squamous cells. One treatment of this type of ung cancer is radioactive implants. Subsequent to surgery radioactive implants are surgically placed which have the capability to emit constant waves of radiation. Treatment may not give 100% guarantee on the recovery of the affected patient from the very rapid spread of squamous cell lung cancer.
